Gastrointestinal Bleeding Treatment Market is expected to reach US$ 1058.61 Mn. at a CAGR of 4.6 % during the forecast period 2029. Gastrointestinal (GI) bleeding is the bleeding of digestive tracts and is a very serious symptom that occurs within the digestive organs such as the esophagus, stomach, small intestine including the duodenum, rectum, etc. Gastrointestinal bleeding is one of the mutual conditions in the emergency department along with abdominal pain.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report The scope of the report includes a detailed study of global and regional markets for global gastrointestinal bleeding treatment market with the reasons given for variations in the growth of the industry in certain regions. The gastrointestinal bleeding treatment market is growing because of the increasing endoscopic hemostasis demand and growing geriatric population base. The population suffering from gastrointestinal bleeding majorly affects the age group above 85 years, as per the U.S National Library of Medicine National Institutes of Health. The problem among the aging population is an epidemiological phenomenon and gastrointestinal bleeding is a rising problem, requiring a solution in daily clinical practice. The report on global gastrointestinal bleeding treatment market covers segments such as product, GI tract division and end-user. Based on GI tract division, upper GI tract accounted for major xx% share in the gastrointestinal bleeding treatment market in 2021 and is expected to register the highest CAGR in the future. The upper GI tract bleeding is between the most common causes of emergencies reported and also accounts for more than 250,000 annual hospitalizations in the U.K and 240,000 in the U.S. North America is expected to command the global market among the estimate time frame inferable from the existence of driving business sector players and key mergers and associations among players. North America, especially The U.S, will still play an important role which cannot be ignored. Any changes from the U.S might affect the development trend of gastrointestinal bleeding treatment.
Gastrointestinal Bleeding Treatment Market Regional Analysis
The competitive landscape section in the gastrointestinal bleeding treatment market offers a deep dive into the profiles of the leading companies operating in the global market landscape. It offers captivating insights on the key developments, differential strategies, and other crucial aspects about the key players having a stronghold in the gastrointestinal bleeding treatment market. The report covers major players like Boston Scientific Corporation, Olympus Corporation, CONMED Corporation and more. The objective of the report is to present comprehensive analysis of Global Gastrointestinal Bleeding Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Gastrointestinal Bleeding Treatment Market dynamics, structure by analyzing the market segments, and project the Global Gastrointestinal Bleeding Treatment Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Gastrointestinal Bleeding Treatment Market make the report investor’s guide.Gastrointestinal Bleeding Treatment Market Scope: Inquire before buying
Global Gastrointestinal Bleeding Treatment Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 738.72 Mn. Forecast Period 2022 to 2029 CAGR: 4.6% Market Size in 2029: US $ 1058.61 Mn. Segments Covered: by Product • Endoscopic Hemostatic Devices • Thermal Devices • Closure Devices • Others by GI Tract Division • Upper GI Tract • Lower GI Tract • Others by End User • Hospitals • Clinics • Ambulatory Surgical Centers • Others Gastrointestinal Bleeding Treatment Market, by Region
• North America • Asia Pacific • Europe • Middle East & Africa • South AmericaGastrointestinal Bleeding Treatment Market Key players are:
• Boston Scientific Corporation • Olympus Corporation • CONMED Corporation • Cook Medical • Ovesco Endoscopy AG • Erbe Elektromedizin GmbH • STERIS PLC • US Medical Innovations, LLC. • Mayo foundation for medical education and research • pfizer inc • Ovesco Endoscopy USA • Austin Gastroenterology • Digestive Disorders Associates & MDTEC • Gastro Liver Care Frequently Asked Questions: 1. Which region has the largest share in Global Gastrointestinal Bleeding Treatment Market? Ans: North America region held the highest share in 2021. 2. What is the growth rate of Global Gastrointestinal Bleeding Treatment Market? Ans: The Global Gastrointestinal Bleeding Treatment Market is growing at a CAGR of 4.6 % during forecasting period 2022-2029. 3. What is scope of the Global Gastrointestinal Bleeding Treatment market report? Ans: Global Gastrointestinal Bleeding Treatment Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Gastrointestinal Bleeding Treatment market? Ans: The important key players in the Global Gastrointestinal Bleeding Treatment Market are – Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS PLC, US Medical Innovations, LLC., Mayo foundation for medical education and research, pfizer inc, Ovesco Endoscopy USA, Austin Gastroenterology, Digestive Disorders Associates & MDTEC, and Gastro Liver Care 5. What is the study period of this market? Ans: The Global Gastrointestinal Bleeding Treatment Market is studied from 2021 to 2029.
Global Gastrointestinal Bleeding Treatment Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Gastrointestinal Bleeding Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast 6.1. Global Gastrointestinal Bleeding Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, By Product 7.4. Global Gastrointestinal Bleeding Treatment Market Size (US$ Bn) Forecast, By Product 7.5. Global Gastrointestinal Bleeding Treatment Market Analysis, By Product 7.6. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, By Product 8. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, By GI Tract Division 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, By GI Tract Division 8.4. Global Gastrointestinal Bleeding Treatment Market Size (US$ Bn) Forecast, By GI Tract Division 8.5. Global Gastrointestinal Bleeding Treatment Market Analysis, By GI Tract Division 8.6. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, By GI Tract Division 9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, By End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, By End User 9.4. Global Gastrointestinal Bleeding Treatment Market Size (US$ Bn) Forecast, By End User 9.5. Global Gastrointestinal Bleeding Treatment Market Analysis, By End User 9.6. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, By End User 10. Global Gastrointestinal Bleeding Treatment Market Analysis, by Region 10.1. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Region 10.2. Global Gastrointestinal Bleeding Treatment Market Size (US$ Bn) Forecast, by Region 10.3. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Region 11. North America Gastrointestinal Bleeding Treatment Market Analysis 11.1. Key Findings 11.2. North America Gastrointestinal Bleeding Treatment Market Overview 11.3. North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, By Product 11.4. North America Gastrointestinal Bleeding Treatment Market Forecast, By Product 11.4.1. Endoscopic Hemostatic Devices 11.4.2. Thermal Devices 11.4.3. Closure Devices 11.4.4. Others 11.5. North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, By GI Tract Division 11.6. North America Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 11.6.1. Upper GI Tract 11.6.2. Lower GI Tract 11.6.3. Other 11.7. North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, By End User 11.8. North America Gastrointestinal Bleeding Treatment Market Forecast, By End User 11.8.1. Hospitals 11.8.2. Clinics 11.8.3. Ambulatory Surgical Centers 11.8.4. Others 11.9. North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country 11.10. North America Gastrointestinal Bleeding Treatment Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Gastrointestinal Bleeding Treatment Market Analysis, by Country 11.12. U.S. Gastrointestinal Bleeding Treatment Market Forecast, By Product 11.12.1. Endoscopic Hemostatic Devices 11.12.2. Thermal Devices 11.12.3. Closure Devices 11.12.4. Others 11.13. U.S. Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 11.13.1. Upper GI Tract 11.13.2. Lower GI Tract 11.13.3. Other 11.14. U.S. Gastrointestinal Bleeding Treatment Market Forecast, By End User 11.14.1. Hospitals 11.14.2. Clinics 11.14.3. Ambulatory Surgical Centers 11.14.4. Others 11.15. Canada Gastrointestinal Bleeding Treatment Market Forecast, By Product 11.15.1. Endoscopic Hemostatic Devices 11.15.2. Thermal Devices 11.15.3. Closure Devices 11.15.4. Others 11.16. Canada Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 11.16.1. Upper GI Tract 11.16.2. Lower GI Tract 11.16.3. Other 11.17. Canada Gastrointestinal Bleeding Treatment Market Forecast, By End User 11.17.1. Hospitals 11.17.2. Clinics 11.17.3. Ambulatory Surgical Centers 11.17.4. Others 11.18. North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By GI Tract Division 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Gastrointestinal Bleeding Treatment Market Analysis 12.1. Key Findings 12.2. Europe Gastrointestinal Bleeding Treatment Market Overview 12.3. Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, By Product 12.4. Europe Gastrointestinal Bleeding Treatment Market Forecast, By Product 12.4.1. Endoscopic Hemostatic Devices 12.4.2. Thermal Devices 12.4.3. Closure Devices 12.4.4. Others 12.5. Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, By GI Tract Division 12.6. Europe Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 12.6.1. Upper GI Tract 12.6.2. Lower GI Tract 12.6.3. Other 12.7. Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, By End User 12.8. Europe Gastrointestinal Bleeding Treatment Market Forecast, By End User 12.8.1. Hospitals 12.8.2. Clinics 12.8.3. Ambulatory Surgical Centers 12.8.4. Others 12.9. Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country 12.10. Europe Gastrointestinal Bleeding Treatment Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Gastrointestinal Bleeding Treatment Market Analysis, by Country 12.12. Germany Gastrointestinal Bleeding Treatment Market Forecast, By Product 12.12.1. Endoscopic Hemostatic Devices 12.12.2. Thermal Devices 12.12.3. Closure Devices 12.12.4. Others 12.13. Germany Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 12.13.1. Upper GI Tract 12.13.2. Lower GI Tract 12.13.3. Other 12.14. Germany Gastrointestinal Bleeding Treatment Market Forecast, By End User 12.14.1. Hospitals 12.14.2. Clinics 12.14.3. Ambulatory Surgical Centers 12.14.4. Others 12.15. U.K. Gastrointestinal Bleeding Treatment Market Forecast, By Product 12.15.1. Endoscopic Hemostatic Devices 12.15.2. Thermal Devices 12.15.3. Closure Devices 12.15.4. Others 12.16. U.K. Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 12.16.1. Upper GI Tract 12.16.2. Lower GI Tract 12.16.3. Other 12.17. U.K. Gastrointestinal Bleeding Treatment Market Forecast, By End User 12.17.1. Hospitals 12.17.2. Clinics 12.17.3. Ambulatory Surgical Centers 12.17.4. Others 12.18. France Gastrointestinal Bleeding Treatment Market Forecast, By Product 12.18.1. Endoscopic Hemostatic Devices 12.18.2. Thermal Devices 12.18.3. Closure Devices 12.18.4. Others 12.19. France Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 12.19.1. Upper GI Tract 12.19.2. Lower GI Tract 12.19.3. Other 12.20. France Gastrointestinal Bleeding Treatment Market Forecast, By End User 12.20.1. Hospitals 12.20.2. Clinics 12.20.3. Ambulatory Surgical Centers 12.20.4. Others 12.21. Italy Gastrointestinal Bleeding Treatment Market Forecast, By Product 12.21.1. Endoscopic Hemostatic Devices 12.21.2. Thermal Devices 12.21.3. Closure Devices 12.21.4. Others 12.22. Italy Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 12.22.1. Upper GI Tract 12.22.2. Lower GI Tract 12.22.3. Other 12.23. Italy Gastrointestinal Bleeding Treatment Market Forecast, By End User 12.23.1. Hospitals 12.23.2. Clinics 12.23.3. Ambulatory Surgical Centers 12.23.4. Others 12.24. Spain Gastrointestinal Bleeding Treatment Market Forecast, By Product 12.24.1. Endoscopic Hemostatic Devices 12.24.2. Thermal Devices 12.24.3. Closure Devices 12.24.4. Others 12.25. Spain Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 12.25.1. Upper GI Tract 12.25.2. Lower GI Tract 12.25.3. Other 12.26. Spain Gastrointestinal Bleeding Treatment Market Forecast, By End User 12.26.1. Hospitals 12.26.2. Clinics 12.26.3. Ambulatory Surgical Centers 12.26.4. Others 12.27. Rest of Europe Gastrointestinal Bleeding Treatment Market Forecast, By Product 12.27.1. Endoscopic Hemostatic Devices 12.27.2. Thermal Devices 12.27.3. Closure Devices 12.27.4. Others 12.28. Rest of Europe Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 12.28.1. Upper GI Tract 12.28.2. Lower GI Tract 12.28.3. Other 12.29. Rest Of Europe Gastrointestinal Bleeding Treatment Market Forecast, By End User 12.29.1. Hospitals 12.29.2. Clinics 12.29.3. Ambulatory Surgical Centers 12.29.4. Others 12.30. Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By GI Tract Division 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Gastrointestinal Bleeding Treatment Market Overview 13.3. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, By Product 13.4. Asia Pacific Gastrointestinal Bleeding Treatment Market Forecast, By Product 13.4.1. Endoscopic Hemostatic Devices 13.4.2. Thermal Devices 13.4.3. Closure Devices 13.4.4. Others 13.5. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, By GI Tract Division 13.6. Asia Pacific Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 13.6.1. Upper GI Tract 13.6.2. Lower GI Tract 13.6.3. Other 13.7. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, By End User 13.8. Asia Pacific Gastrointestinal Bleeding Treatment Market Forecast, By End User 13.8.1. Hospitals 13.8.2. Clinics 13.8.3. Ambulatory Surgical Centers 13.8.4. Others 13.9. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country 13.10. Asia Pacific Gastrointestinal Bleeding Treatment Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis, by Country 13.12. China Gastrointestinal Bleeding Treatment Market Forecast, By Product 13.12.1. Endoscopic Hemostatic Devices 13.12.2. Thermal Devices 13.12.3. Closure Devices 13.12.4. Others 13.13. China Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 13.13.1. Upper GI Tract 13.13.2. Lower GI Tract 13.13.3. Other 13.14. China Gastrointestinal Bleeding Treatment Market Forecast, By End User 13.14.1. Hospitals 13.14.2. Clinics 13.14.3. Ambulatory Surgical Centers 13.14.4. Others 13.15. India Gastrointestinal Bleeding Treatment Market Forecast, By Product 13.15.1. Endoscopic Hemostatic Devices 13.15.2. Thermal Devices 13.15.3. Closure Devices 13.15.4. Others 13.16. India Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 13.16.1. Upper GI Tract 13.16.2. Lower GI Tract 13.16.3. Other 13.17. India Gastrointestinal Bleeding Treatment Market Forecast, By End User 13.17.1. Hospitals 13.17.2. Clinics 13.17.3. Ambulatory Surgical Centers 13.17.4. Others 13.18. Japan Gastrointestinal Bleeding Treatment Market Forecast, By Product 13.18.1. Endoscopic Hemostatic Devices 13.18.2. Thermal Devices 13.18.3. Closure Devices 13.18.4. Others 13.19. Japan Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 13.19.1. Upper GI Tract 13.19.2. Lower GI Tract 13.19.3. Other 13.20. Japan Gastrointestinal Bleeding Treatment Market Forecast, By End User 13.20.1. Hospitals 13.20.2. Clinics 13.20.3. Ambulatory Surgical Centers 13.20.4. Others 13.21. ASEAN Gastrointestinal Bleeding Treatment Market Forecast, By Product 13.21.1. Endoscopic Hemostatic Devices 13.21.2. Thermal Devices 13.21.3. Closure Devices 13.21.4. Others 13.22. ASEAN Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 13.22.1. Upper GI Tract 13.22.2. Lower GI Tract 13.22.3. Other 13.23. ASEAN Gastrointestinal Bleeding Treatment Market Forecast, By End User 13.23.1. Hospitals 13.23.2. Clinics 13.23.3. Ambulatory Surgical Centers 13.23.4. Others 13.24. Rest of Asia Pacific Gastrointestinal Bleeding Treatment Market Forecast, By Product 13.24.1. Endoscopic Hemostatic Devices 13.24.2. Thermal Devices 13.24.3. Closure Devices 13.24.4. Others 13.25. Rest of Asia Pacific Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 13.25.1. Upper GI Tract 13.25.2. Lower GI Tract 13.25.3. Other 13.26. Rest of Asia Pacific Gastrointestinal Bleeding Treatment Market Forecast, By End User 13.26.1. Hospitals 13.26.2. Clinics 13.26.3. Ambulatory Surgical Centers 13.26.4. Others 13.27. Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By GI Tract Division 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Gastrointestinal Bleeding Treatment Market Overview 14.3. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, By Product 14.4. Middle East & Africa Gastrointestinal Bleeding Treatment Market Forecast, By Product 14.4.1. Endoscopic Hemostatic Devices 14.4.2. Thermal Devices 14.4.3. Closure Devices 14.4.4. Others 14.5. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, By GI Tract Division 14.6. Middle East & Africa Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 14.6.1. Upper GI Tract 14.6.2. Lower GI Tract 14.6.3. Other 14.7. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, By End User 14.8. Middle East & Africa Gastrointestinal Bleeding Treatment Market Forecast, By End User 14.8.1. Hospitals 14.8.2. Clinics 14.8.3. Ambulatory Surgical Centers 14.8.4. Others 14.9. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country 14.10. Middle East & Africa Gastrointestinal Bleeding Treatment Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis, by Country 14.12. GCC Gastrointestinal Bleeding Treatment Market Forecast, By Product 14.12.1. Endoscopic Hemostatic Devices 14.12.2. Thermal Devices 14.12.3. Closure Devices 14.12.4. Others 14.13. GCC Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 14.13.1. Upper GI Tract 14.13.2. Lower GI Tract 14.13.3. Other 14.14. GCC Gastrointestinal Bleeding Treatment Market Forecast, By End User 14.14.1. Hospitals 14.14.2. Clinics 14.14.3. Ambulatory Surgical Centers 14.14.4. Others 14.15. South Africa Gastrointestinal Bleeding Treatment Market Forecast, By Product 14.15.1. Endoscopic Hemostatic Devices 14.15.2. Thermal Devices 14.15.3. Closure Devices 14.15.4. Others 14.16. South Africa Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 14.16.1. Upper GI Tract 14.16.2. Lower GI Tract 14.16.3. Other 14.17. South Africa Gastrointestinal Bleeding Treatment Market Forecast, By End User 14.17.1. Hospitals 14.17.2. Clinics 14.17.3. Ambulatory Surgical Centers 14.17.4. Others 14.18. Rest of Middle East & Africa Gastrointestinal Bleeding Treatment Market Forecast, By Product 14.18.1. Endoscopic Hemostatic Devices 14.18.2. Thermal Devices 14.18.3. Closure Devices 14.18.4. Others 14.19. Rest of Middle East & Africa Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 14.19.1. Upper GI Tract 14.19.2. Lower GI Tract 14.19.3. Other 14.20. Rest of Middle East & Africa Gastrointestinal Bleeding Treatment Market Forecast, By End User 14.20.1. Hospitals 14.20.2. Clinics 14.20.3. Ambulatory Surgical Centers 14.20.4. Others 14.21. Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By GI Tract Division 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Gastrointestinal Bleeding Treatment Market Analysis 15.1. Key Findings 15.2. South America Gastrointestinal Bleeding Treatment Market Overview 15.3. South America Gastrointestinal Bleeding Treatment Market Value Share Analysis, By Product 15.4. South America Gastrointestinal Bleeding Treatment Market Forecast, By Product 15.4.1. Endoscopic Hemostatic Devices 15.4.2. Thermal Devices 15.4.3. Closure Devices 15.4.4. Others 15.5. South America Gastrointestinal Bleeding Treatment Market Value Share Analysis, By GI Tract Division 15.6. South America Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 15.6.1. Upper GI Tract 15.6.2. Lower GI Tract 15.6.3. Other 15.7. South America Gastrointestinal Bleeding Treatment Market Value Share Analysis, By End User 15.8. South America Gastrointestinal Bleeding Treatment Market Forecast, By End User 15.8.1. Hospitals 15.8.2. Clinics 15.8.3. Ambulatory Surgical Centers 15.8.4. Others 15.9. South America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country 15.10. South America Gastrointestinal Bleeding Treatment Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Gastrointestinal Bleeding Treatment Market Analysis, by Country 15.12. Brazil Gastrointestinal Bleeding Treatment Market Forecast, By Product 15.12.1. Endoscopic Hemostatic Devices 15.12.2. Thermal Devices 15.12.3. Closure Devices 15.12.4. Others 15.13. Brazil Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 15.13.1. Upper GI Tract 15.13.2. Lower GI Tract 15.13.3. Other 15.14. Brazil Gastrointestinal Bleeding Treatment Market Forecast, By End User 15.14.1. Hospitals 15.14.2. Clinics 15.14.3. Ambulatory Surgical Centers 15.14.4. Others 15.15. Mexico Gastrointestinal Bleeding Treatment Market Forecast, By Product 15.15.1. Endoscopic Hemostatic Devices 15.15.2. Thermal Devices 15.15.3. Closure Devices 15.15.4. Others 15.16. Mexico Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 15.16.1. Upper GI Tract 15.16.2. Lower GI Tract 15.16.3. Other 15.17. Mexico Gastrointestinal Bleeding Treatment Market Forecast, By End User 15.17.1. Hospitals 15.17.2. Clinics 15.17.3. Ambulatory Surgical Centers 15.17.4. Others 15.18. Rest of South America Gastrointestinal Bleeding Treatment Market Forecast, By Product 15.18.1. Endoscopic Hemostatic Devices 15.18.2. Thermal Devices 15.18.3. Closure Devices 15.18.4. Others 15.19. Rest of South America Gastrointestinal Bleeding Treatment Market Forecast, By GI Tract Division 15.19.1. Upper GI Tract 15.19.2. Lower GI Tract 15.19.3. Other 15.20. Rest of South America Gastrointestinal Bleeding Treatment Market Forecast, By End User 15.20.1. Hospitals 15.20.2. Clinics 15.20.3. Ambulatory Surgical Centers 15.20.4. Others 15.21. South America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By GI Tract Division 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Boston Scientific Corporation 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Comapny Footprint 16.3.2. Olympus Corporation 16.3.3. CONMED Corporation 16.3.4. Cook Medical 16.3.5. Ovesco Endoscopy AG 16.3.6. Erbe Elektromedizin GmbH 16.3.7. STERIS PLC 16.3.8. US Medical Innovations, LLC. 16.3.9. mayo foundation for medical education and research 16.3.10. pfizer inc 16.3.11. Ovesco Endoscopy USA 16.3.12. Austin Gastroenterology 16.3.13. Digestive Disorders Associates & MDTEC 16.3.14. Gastro Liver Care 17. Primary Key Insights